Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity matched multicenter case-control study
- Chinthaka B. Samaranayake1,
- Gregory Keir1,2,
- Simon A. A. Slader2,
- T Tseng2,
- Khoa Tran1,3,
- James Anderson4,5,
- Andrew McCann2,
- Colm McCabe6,7 and
- John W. Upham1,2
- 1Faculty of Medicine, University of Queensland, Brisbane, Australia
- 2Princess Alexandra Hospital, Brisbane, Queensland, Australia
- 3Logan Hospital, Brisbane, Queensland, Australia
- 4Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
- 5School of Medicine, Griffith University, Southport, Queensland, Australia
- 6Royal Brompton & Harefield National Health Service Trust, London, UK
- 7National Heart and Lung Institute, Imperial College, London, UK
- Corresponding author: Chinthaka Samaranayake (c.samaranayake{at}uq.edu.au)
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Samaranayake has nothing to disclose.
Conflict of interest: Dr. Keir has nothing to disclose.
Conflict of interest: Dr. Slader has nothing to disclose.
Conflict of interest: Dr. Tseng has nothing to disclose.
Conflict of interest: Dr. Tran has nothing to disclose.
Conflict of interest: Dr. Anderson has nothing to disclose.
Conflict of interest: Dr. McCann has nothing to disclose.
Conflict of interest: Dr. McCabe has nothing to disclose.
Conflict of interest: Dr. Upham has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received March 26, 2021.
- Accepted June 27, 2021.
- Copyright ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org